EFFECT OF ENZYME-INDUCTION ON DIAZEPAM METABOLISM IN MAN

被引:30
作者
OHNHAUS, EE
PARK, BK
COLOMBO, JP
HEIZMANN, P
机构
[1] UNIV LIVERPOOL,DEPT PHARMACOL & THERAPEUT,LIVERPOOL L69 3BX,MERSEYSIDE,ENGLAND
[2] UNIV BERN,INSELSPITAL,DEPT MED,CH-3010 BERN,SWITZERLAND
[3] UNIV BERN,INSELSPITAL,DEPT CLIN CHEM,CH-3010 BERN,SWITZERLAND
关键词
D O I
10.1111/j.1365-2125.1979.tb01044.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The elimination and metabolism of diazepam in man was investigated following the induction of the liver microsomal enzyme system by antipyrine. 2 Seven healthy volunteers were given 1200 mg antipyrine as an inducing agent for a period of 14 days. Before and after the induction period the elimination of diazepam and desmethyldiazepam was measured in the plasma by gaschromatography. As parameters of liver microsomal enzyme activity, antipyrine elimination and gamma‐glutamyl‐ transpeptidase in the plasma, D‐glucaric acid and 6‐beta‐ hydroxycortisol urinary excretion were measured on both occasions. 3 Following the induction period most parameters of microsomal enzyme activity measured were significantly changed indicating an increase of the microsomal enzyme system. The elimination of diazepam was significantly altered having a half‐life of 37 h before and 18 h afterwards combined with a significant increase in total body clearance after the induction period, although the volume of distribution remained unaltered. The formation of the main metabolite N‐ desmethyldiazepam was not changed, but its elimination was increased having a half‐life of 139 or 58 h respectively. 4 The elimination of unchanged diazepam and desmethyldiazepam is significantly increased by the induction of the liver microsomal enzyme system using antipyrine as an inducing agent in healthy volunteers, which might be important under certain clinical conditions. 1979 The British Pharmacological Society
引用
收藏
页码:557 / 563
页数:7
相关论文
共 18 条
[2]  
BRODIE BB, 1949, J BIOL CHEM, V179, P25
[3]   URINARY D-GLUCARIC ACID EXCRETION AND PLASMA ANTIPYRINE KINETICS DURING ENZYME-INDUCTION [J].
DAVIS, M ;
SIMMONS, CJ ;
DORDONI, B ;
WILLIAMS, R .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 1 (03) :253-257
[4]   DETERMINATION OF 1,4-BENZODIAZEPINES AND 1,4-BENZODIAZEPINE-2-ONES IN BLOOD BY ELECTRON-CAPTURE GAS-LIQUID-CHROMATOGRAPHY [J].
DESILVA, JAF ;
BEKERSKY, I ;
PUGLISI, CV ;
BROOKS, MA ;
WEINFELD, RE .
ANALYTICAL CHEMISTRY, 1976, 48 (01) :10-19
[5]   STIMULATORY EFFECTS OF CHLORDIAZEPOXIDE, DIAZEPAM AND OXAZEPAM ON DRUG-METABOLIZING-ENZYMES IN MICROSOMES [J].
JABLONSKA, JK ;
KNOBLOCH, K ;
MAJKA, J ;
WISNIEWSKAKNYPL, JM .
TOXICOLOGY, 1975, 5 (01) :103-111
[6]   PHARMACOKINETIC PROFILE OF DIAZEPAM IN MAN FOLLOWING SINGLE INTRAVENOUS AND ORAL AND CHRONIC ORAL ADMINISTRATIONS [J].
KAPLAN, SA ;
JACK, ML ;
ALEXANDER, K ;
WEINFELD, RE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (11) :1789-1796
[7]   COMPARISON OF PHARMACOKINETICS OF DIAZEPAM AFTER SINGLE AND SUBCHRONIC DOSES [J].
KLOTZ, U ;
ANTONIN, KH ;
BIECK, PR .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 10 (02) :121-126
[9]  
MARUCCI F, 1970, BIOCH PHARM, V19, P1771
[10]   ENZYME-INDUCTION AND RENAL-FUNCTION IN MAN [J].
OHNHAUS, EE ;
MARTIN, J ;
KINSER, J ;
COLOMBO, JP .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (01) :33-37